Number of pages: 100 | Report Format: PDF | Published date: May 26, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
According to the deep-dive market assessment study by Growth Plus Reports, the global southern blotting market was valued at US$ 2.13 billion in 2022 and is expected to register a revenue CAGR of 4.90% to reach US$ 3.27 billion by 2031.
Southern Blotting Market Fundamentals
Southern blotting is a fundamental molecular biology technique that has revolutionized the study of DNA sequences. The technique is named after its inventor and has become an indispensable tool in genetics and genomics research. This powerful method has enabled scientists to explore gene expression patterns, identify genetic mutations, investigate DNA methylation patterns, and study various aspects of genomic organization.
Despite the emergence of newer technologies, southern blotting remains significant in specific research applications, owing to its ability to provide accurate and detailed information about DNA sequences. Over the years, the market has witnessed some new trends that are shaping the southern blotting market, such as the development of automated and streamlined southern blotting systems. Market players have introduced innovative platforms that simplify the workflow, reduce processing time, and improve reproducibility. These automated systems offer improved accuracy and efficiency, making Southern blotting more accessible to researchers and increasing its adoption in various laboratories. Furthermore, a growing focus is on improving sensitivity and detection limits in Southern blotting.
Efforts are being made to enhance probe design, labeling techniques, and detection methods to achieve higher sensitivity and reduce background noise. These advancements enable researchers to detect rare genetic variants and low-abundance DNA sequences with greater precision.
Southern Blotting Market Dynamics
The rising prevalence of genetic diseases and the increasing popularity of personalized medicine support the global southern blotting market. There are an estimated 10,000 different types of single-gene diseases (also called monogenic diseases), which are diseases caused by mutations in a single gene. The World Health Organization estimates that 10 out of every 1000 people are affected. This means between 70 million and 80 million people worldwide live with one of these diseases. Southern blotting plays a significant role in identifying genetic mutations and rare genetic variants, which are crucial in personalized medicine. It allows for precisely detecting and characterizing specific DNA sequences associated with genetic disorders or disease susceptibility.
Companies in the market are investing in research and development to improve the southern blotting technique. They are creating sophisticated reagents, kits, and instruments that provide better sensitivity, increased throughput, and more streamlined workflows. These technological advancements appeal to researchers seeking more efficient and dependable methods for genetic studies. Providing innovative solutions can increase a company's revenue by meeting the demand for improved southern blotting techniques.
The field of epigenetics, which explores heritable changes in gene expression that do not involve changes to DNA sequence, has become increasingly popular in recent times. Southern blotting is crucial in examining DNA methylation patterns, a significant epigenetic modification. As the scope of epigenetic research expands and our comprehension of the role of epigenetics in various illnesses deepens, the demand for Southern blotting to investigate DNA methylation and other epigenetic modifications continues to rise.
However, the emergence of advanced molecular diagnostic methods, such as PCR-based assays, next-generation sequencing, and microarray technologies, has provided alternative options for DNA analysis. These techniques offer higher throughput, increased sensitivity, and quantitative capabilities, which can overshadow the usage of Southern blotting in certain applications. Researchers may opt for these alternative techniques based on their specific research needs.
Southern Blotting Market Ecosystem
The global Southern blotting market is analyzed from four perspectives: products, application, end user and region.
Southern Blotting Market by Products
Based on the products, the global Southern blotting market is segmented into consumables and instruments.
The consumables segment accounted for the majority of Southern blotting market revenue share in 2022. This is mainly because Southern blotting experiments require reagents and probes constantly. As long as researchers continue to use Southern blotting for a variety of purposes, such as gene expression analysis and disease diagnosis, the demand for consumables is predicted to remain high. The availability of a broad range of superior consumables from reputable manufacturers is also anticipated to contribute to the segment's continued growth. Due to the frequent use of consumables during Southern blotting procedures, this is understandable. Consumables like nitrocellulose membranes, buffers, and reagents are crucial to the Southern blotting process and must be replaced after each use.
The instruments segment is expected to increase by 4.9% of revenue CAGR in the forecast period. This is primarily due to the rising demand for cutting-edge surgical equipment and increased surgical procedures being carried out globally. The prevalence of chronic diseases like cancer and cardiovascular diseases is rising, which has increased the need for surgical interventions and raised the price of surgical equipment. In addition, it is anticipated that the growing popularity of minimally invasive procedures and the creation of cutting-edge instruments will fuel the expansion of the instrument market.
Southern Blotting Market Application
Based on the applications, the global Southern blotting market is segmented into medical diagnosis, genetic fingerprinting, scientific research, agriculture, and sex determination.
The scientific research segment dominated the global Southern blotting market with a high revenue share. This is attributed to the increase in demand for cutting-edge technologies and research tools in the fields of genomics and proteomics. The use of Southern blotting techniques in research and diagnosis has also grown as genetic disorders and cancer are becoming more common. In addition, the presence of major market players in the area and the availability of funding for genomic research have fueled the expansion of the Southern blotting market in the scientific research sector.
The disease diagnostics segment is expected to show 5.2% CAGR in the forecast years. This is due to the increase in genetic disorders and infectious diseases, both of which necessitate precise and effective diagnostic equipment. Southern blotting is a common method for identifying and examining DNA sequences, making it an important tool for investigating and diagnosing disease. Southern blotting has become more accessible and user-friendly thanks to technological developments and the availability of automated systems, increasing its demand in the healthcare sector.
Southern Blotting Market by End User
Based on the end users, the global Southern blotting market is segmented into biotechnology & pharmaceutical industries, research institutes, and contract research organizations.
The pharmaceutical and biotechnology industry segment has dominated the global Southern blotting market. This is due to the significant research and development investments and their focus on drug discovery and development processes. The pharmaceutical and biotechnology industry heavily relies on molecular biology techniques, including Southern blotting, to understand disease mechanisms, identify potential drug targets, and assess the efficacy of drug candidates.
Additionally, the pharmaceutical and biotechnology industries have the necessary infrastructure and expertise to conduct molecular biology experiments, including Southern blotting, on a large scale. They possess well-equipped laboratories, skilled scientists, and established protocols for implementing Southern blotting techniques. This enables them to efficiently integrate Southern blotting into their drug discovery and development processes, making it a preferred method for genetic analysis.
Southern Blotting Market by Region
Based on the regions, the global Southern blotting market is segmented into North America, Europe, Asia Pacific, Latin America, & the Middle East & Africa.
North America accounted for most of the Southern blotting market revenue share in 2022. This is because North America, particularly the United States, is home to a robust biotechnology and pharmaceutical industry. The region has many research institutions, biotech companies, and pharmaceutical companies that heavily invest in molecular biology research and development. These organizations contribute significantly to the demand for Southern blotting products and technologies, thereby driving the market revenue in the region.
The Asia Pacific Southern Blotting Market is projected to show a significant growth of 6.45% CAGR in the forecast period. The Asia Pacific region has witnessed remarkable growth in research and development activities, particularly in the field of molecular biology. Academic institutions, research organizations, and biotechnology companies in countries like China, India, Japan, and South Korea are actively engaged in genetic research. With its ability to analyze specific DNA sequences, Southern blotting has become a valuable tool in studying genetic variations and mutations associated with various diseases and conditions.
Molecular diagnostics Competitive Landscape
Several companies emphasize growth strategies, such as new launches, product approvals, and other elements like patents and events. The market saw acquisition, partnership, and cooperation activities as inorganic development strategies. These initiatives have enabled the expansion of future economic business prospects and increased demand for calcitonin in the global Southern blotting market.
Some of the prominent companies having the largest revenue share in the global southern blotting market are,
Southern blotting is a fundamental molecular biology technique that has revolutionized the study of DNA sequences.
The global Southern blotting market was valued at US$ 3.27 billion by 2031.
The global Southern blotting market has witnessed significant growth over the years, owing to the increasing demand for genetic analysis in various industries such as pharmaceuticals, biotechnology, and clinical diagnostics.
The global Southern blotting market is expected to register a revenue CAGR of 4.90% in the forecast period from 2013 to 2031.
North America region has dominated the global Southern blotting market.
*Insights on financial performance are subject to the availability of information in the public domain